13-49482866-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001160308.3(SETDB2):āc.1286T>Cā(p.Val429Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,613,598 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001160308.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SETDB2 | NM_001160308.3 | c.1286T>C | p.Val429Ala | missense_variant | 9/14 | ENST00000611815.2 | NP_001153780.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SETDB2 | ENST00000611815.2 | c.1286T>C | p.Val429Ala | missense_variant | 9/14 | 5 | NM_001160308.3 | ENSP00000482240.2 | ||
SETDB2 | ENST00000354234.8 | c.1322T>C | p.Val441Ala | missense_variant | 10/15 | 1 | ENSP00000346175.5 | |||
SETDB2 | ENST00000317257.12 | c.1286T>C | p.Val429Ala | missense_variant | 8/13 | 1 | ENSP00000326477.9 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251166Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135770
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461264Hom.: 0 Cov.: 30 AF XY: 0.00000963 AC XY: 7AN XY: 726956
GnomAD4 genome AF: 0.0000853 AC: 13AN: 152334Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74496
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 04, 2024 | The c.1322T>C (p.V441A) alteration is located in exon 10 (coding exon 9) of the SETDB2 gene. This alteration results from a T to C substitution at nucleotide position 1322, causing the valine (V) at amino acid position 441 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at